MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia"

  • 2016 International Congress

    Dementia in adult type 2 diabetes patients – An analysis from the multicenter German/Austrian diabetes patient follow-up registry DPV

    N. Prinz, L. Wang, J. Stingl, M.D. Denkinger, P. Fasching, P.M. Jehle, S. Merger, S. Mühldorfer, A. Schuler, A. Zeyfang, M. Sharma, R.W. Holl (Ulm, Germany)

    Objective: To study the presence of dementia in older people with Type 2 diabetes mellitus (T2DM) and to compare demographics with non-demented T2DM patients. Background:…
  • 2016 International Congress

    Predictive performance of EEG theta spectral power over developing dementia in Parkinson’s disease

    V.V. Cozac, M. Chaturvedi, U. Gschwandtner, F. Hatz, A. Meyer, K. Nowak, R. Sturzenegger, P. Fuhr (Basel, Switzerland)

    Objective: To investigate whether changes in EEG power spectra could predict development of dementia in Parkinson's disease (PD-D). Background: Different research groups have reported, that…
  • 2016 International Congress

    Screening of posterior cortical dysfunction in early Parkinson’s disease with mild cognitive impairment as an approach to select patients at higher risk for developing dementia

    H. Bejr-Kasem, J. Pagonabarraga, R. Fernandez-Bobadilla, J. Perez-Perez, J. Marin-Lahoz, B. Pascual-Sedano, S. Martínez-Horta, J. Kulisevsky (Barcelona, Spain)

    Objective: Based on the importance of progressive dysfunction of posterior cortical regions in cognitive deterioration in PD, we explored whether posterior cortical dysfunction in early…
  • 2016 International Congress

    Use of dementia rating scale-II (DRS-II) total score in PD deep brain stimulation (DBS) candidacy determination

    M.J. Sollman, J.G. Hesse, B.C. Sachs, J.F. Cook (Winston-Salem, NC, USA)

    Objective: To evaluate utility of the DRS-II Total Score for stratifying cognitive status in PD patients without frank cognitive impairment. Background: The DRS-II, a screening…
  • 2016 International Congress

    Cognitive decline in Parkinson’s disease: Impact on quality of life of caregivers

    R.A. Lawson, A.J. Yarnall, G.W. Duncan, F. Johnston, T.K. Khoo, D. Collerton, J.P. Taylor, D.J. Burn (Newcastle upon Tyne, United Kingdom)

    Objective: This study aimed to investigate the impact of cognitive impairment in Parkinson's disease (PD) on the quality of life (QoL) of carers. Background: The…
  • 2016 International Congress

    Does cognitive decline contribute to poorer quality of life in incident Parkinson’s disease? A three year follow up

    R.A. Lawson, A.J. Yarnall, G.W. Duncan, D.P. Breen, T.K. Khoo, C.H. Williams-Gray, R.A. Barker, D. Collerton, J.P. Taylor, D.J. Burn (Newcastle upon Tyne, United Kingdom)

    Objective: To investigate the impact of cognition and cognitive decline on quality of life (QoL) in an incident Parkinson's disease (PD) cohort over three years.…
  • 2016 International Congress

    Reliability of verbal and written trail test for individuals with Parkinson’s disease: Is it a good cognitive test?

    M.R. Olchik, M. Ghisi, A. Freiry, A.F.S. Schuh, C.R.M. Rieder (Porto Alegre, Brazil)

    Objective: To verify if the verbal trail test can replace the written trail test, seeing that individuals with PD show considerable motor abnormalities that can…
  • 2016 International Congress

    Treatment with the use of the PD-specific scales for patients suffering from subcortical Parkinsonian dementia

    N.G. Sokhibnazarov, F.K. Shermukhamedova (Tashkent, Uzbekistan)

    Objective: Aim of this study was to identify the degree of cognitive dysfunction in patients with subcortical Parkinsonian dementia, during the neuroprotective therapy. Background: Parkinson's…
  • 2016 International Congress

    Life expectancy and dementia – Two sides of the coin in Parkinson’s disease

    S. Tursunov, G. Rakhimbaeva, F. Yunusov, K. Abdukhalimova, R. Agzamov, R. Mirzaev, D. Lutfullaeva, J. Olimov (Tashkent, Uzbekistan)

    Objective: Our primary aim was to evaluate whether Parkinson's disease is associated with an increased risk of dementia and death. Background: The prevalence of Parkinson's…
  • 2016 International Congress

    Validation of the Seoul-instrumental activity of daily living in the detection of dementia in Parkinson’s disease

    S.J. Kim, E.J. Chung (Busan, Korea)

    Objective: Seoul instrumental activity of daily living (S-iADL) scale is well known to the tool for instrumental activities of Korean elders. However, cutoff point of…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley